Text Size

Wound Healing Response After Bleb-Forming Glaucoma Surgery With a SIBS Microshunt in Rabbits

van Mechelen R.J.S., Wolters J.E.J., Herfs M., Bertens C.J.F., Gijbels M., Pinchuk L., Gorgels T.G.M.F., Beckers H.J.M.


  • 2022
  • Translational vision science & technology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, Netherlands; Department of Ophthalmology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Chemelot Institute for Science and Technology, Maastricht, Netherlands; Department of Pathology, Cardiovascular Research Institute Maastricht, School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; InnFocus, Inc., Miami, FL, United States

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022